Skip to main content
. 2022 Jan 21;11(1):6. doi: 10.1038/s41389-022-00380-z

Fig. 6. CXCR4 colocalizazion with CD138+ cells is higher in MM patients who failed to respond to BTZ.

Fig. 6

The amount of the percentage of CD138+CD38+CXCR4+ cells was assessed in BM (A) and PB (B) samples from MM at diagnosis (n = 30/19) and resistant/refractory patients (n = 18/8). C Analysis of CXCR4 colocalization with CD138+ cells in BM biopsy specimens from patients who responded to BTZ (n = 3) and patients who failed to respond (n = 3). The left panel shows representative pictures of a responder vs a non-responder patient. Scale bar: 10 μm. Bars indicate the standard error means (*p < 0.05).